Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Levofloxacin hydrochloride quick release preparation and preparation method thereof

A levofloxacin hydrochloride, rapid technology, applied in pill delivery, pharmaceutical formulations, medical preparations of non-active ingredients, etc., can solve the problems of no rapid release preparations on the market, poor effect of anaerobic bacteria and enterococci, etc., to improve the dissolution rate and bioavailability

Pending Publication Date: 2021-01-22
CHENGDU HENGRUI PHARMA
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

It also has a good antibacterial effect on Gram-positive bacteria such as methicillin-sensitive Staphylococcus, Streptococcus pneumoniae, Streptococcus pyogenes, and hemolytic streptococcus, as well as Legionella, Mycoplasma, and Chlamydia, but it has no effect on anaerobic bacteria and enterococci. poor
[0003] There are tablets and capsules of levofloxacin hydrochloride preparations on the market, but there is no quick-release preparation on the market

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] A levofloxacin hydrochloride immediate release formulation is made of the following components:

[0024] Levofloxacin hydrochloride 100mg, cross-linked PVP 50mg, carboxymethyl starch sodium 15mg, lactose 20, micronized silica gel 1mg, magnesium stearate 1mg.

Embodiment 2

[0026] A preparation method of levofloxacin hydrochloride quick-release preparation, comprising the following steps:

[0027] Weigh respectively levofloxacin hydrochloride, cross-linked PVP, sodium carboxymethyl starch, lactose, micronized silica gel, magnesium stearate according to the dosage of the components:

[0028] Levofloxacin hydrochloride 200mg, cross-linked PVP 100mg, sodium starch glycolate 45mg, lactose 80mg, micropowder silica gel 10mg, magnesium stearate 2mg;

[0029] Further, pass levofloxacin hydrochloride, cross-linked PVP, sodium starch glycolate, lactose, micronized silica gel, and magnesium stearate through 80-120 sieves;

[0030] Further, the sieved levofloxacin hydrochloride, cross-linked PVP, carboxymethyl starch sodium, and lactose are evenly mixed to obtain a preliminary raw material mixture;

[0031] Further, the micropowder silica gel, magnesium stearate and the preliminary raw material mixture are further mixed, and the final raw material mixture i...

Embodiment 3

[0034] A levofloxacin hydrochloride immediate release formulation is made of the following components:

[0035] Levofloxacin hydrochloride 150mg, cross-linked PVP 75mg, sodium starch glycolate 30mg, lactose 50mg, micronized silica gel 5mg, magnesium stearate 1mg.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of medicine processing, and discloses a levofloxacin hydrochloride quick release preparation and a preparation method thereof. The levofloxacin hydrochloride quick release preparation is prepared from the following components in parts by weight: 100mg-200mg of levofloxacin hydrochloride, 50mg-100mg of cross-linked PVP, 15mg-45mg of carboxymethyl starch sodium, 20-80mg of lactose, 1mg-10mg of aerosil and 1mg-2mg of magnesium stearate. The levofloxacin hydrochloride quick release preparation is prepared from the levofloxacin hydrochloride, a diluent, a disintegrating agent and a lubricating agent, wherein the diluent is the lactose, the disintegrating agent comprises the cross-linked PVP and the carboxymethyl starch sodium, and the lubricating agent is prepared from the aerosil and the magnesium stearate. According to the levofloxacin hydrochloride quick release preparation disclosed by the invention, a powder direct tabletting method is adopted, and the rapid disintegrating agent is added, so that the disintegration performance of the tablet prepared by the invention is not reduced due to early contact with moisture, the medicine exists in an extremely tiny particle, microcrystalline or molecular state, and the disintegrating agent promotes the tablet to disintegrate through capillary action or expansion action. Therefore, aiming at the prior art, the dissolution speed and bioavailability of the medicine can be improved, and the quick-acting and efficient effects are achieved.

Description

technical field [0001] The invention relates to the field of pharmaceutical processing, and relates to a preparation method of a quinolone antibiotic preparation, in particular to a levofloxacin hydrochloride fast-release preparation and a preparation method thereof. Background technique [0002] Levofloxacin hydrochloride is the left-handed body of ofloxacin, and its antibacterial activity is about twice that of ofloxacin. Its main mechanism of action is to inhibit the activity of bacterial DNA gyrase (bacterial topoisomerase II) and hinder bacterial DNA replication. . It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. For most Enterobacteriaceae, such as Escherichia coli, Klebsiella, Serratia, Proteus, Shigella, Salmonella, Citrobacter, Acinetobacter and Pseudomonas aeruginosa Gram-negative bacteria such as Monas, Haemophilus influenzae, and Neisseria gonorrhoeae have strong antibacterial activity. It also has a good antibacteria...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/20A61K47/32A61K47/36A61K47/04A61K47/12A61K31/5383A61P31/04
CPCA61K9/2009A61K9/2013A61K9/2027A61K9/2059A61K9/2095A61K31/5383A61P31/04
Inventor 谢洋刘家俊李雪梅
Owner CHENGDU HENGRUI PHARMA
Features
  • Generate Ideas
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More